Introduction
Antimicrobial resistance (AMR) is a serious and growing global public health threat. In response to this threat, in October 2014 the Government of Canada released Antimicrobial Resistance and Use in Canada: A Federal Framework for Action (1) . The Framework outlines a coordinated, collaborative federal approach to responding to the threat of AMR through action in three areas: surveillance, stewardship, and innovation. Furthermore, the Framework serves as a vehicle to engage partners and stakeholders in discussions on collective actions that can be taken to enhance the effectiveness of individual actions within sectors implicated in AMR.
The Action Plan
As a follow-up to the Framework, the Federal Action Plan on Antimicrobial Resistance and Use in Canada: Building on the Federal Framework for Action (2) was released in March 2015. While the Framework identifies concrete actions by the Government of Canada to reduce the threat and impact of AMR, the purpose of the Action Plan is to outline the specific deliverables being undertaken by federal departments and agencies under each action item, and the targeted completion date for each deliverable. The Action Plan is an evergreen document that will be updated regularly so that it remains reflective of the work that is underway and our plans for the future.
A shared responsibility
As noted in the Framework, addressing the growing threat of AMR in Canada is a shared responsibility that crosses all levels of government (federal, provincial and territorial) and multiple sectors (e.g., public health, health care, animal health, agriculture). When the Framework was released, it outlined the federal role for AMR of several departments: Public Health Agency of Canada Health Canada Canadian Food Inspection Agency Canadian Institutes of Health Research and Agriculture and Agri-food Canada). The scope of work included in the Action Plan has been expanded to include two additional federal departments: Industry Canada and National Research Council Canada.
As indicated in the Framework, provinces, territories, and other stakeholders also play a key role by virtue of their responsibility for the delivery of health care, approval of antimicrobials for medical coverage, and the regulation of antimicrobial use (AMU) in veterinary medicine and agriculture. The Action Plan reaffirms that the Government of Canada is committed to working with all jurisdictions and stakeholders to deliver on the Action Plan.
Leadership
In addition to its work in the areas of surveillance, stewardship and innovation, the Government of Canada is committed to taking a leadership role both nationally and internationally. In support of this commitment, the Action Plan highlights key leadership activities being undertaken. These include: Canada's engagement with international partners on the development and implementation of the World Health Organization's Global Action Plan on AMR; efforts to develop a pan-Canadian approach to address AMR with federal, provincial and territorial (F/P/T) partners, and human health, animal health, agri-food and industry stakeholders; international coordination of research efforts; and, as part of the work under the Global Health Security Agenda, supporting the development of an integrated and global package of activities to combat AMR that spans human, animal, agricultural, food, and environmental sectors.
Surveillance

Action 1: Establish and strengthen surveillance systems to identify new threats or changing patterns in antimicrobial resistance and use, in human and animal settings.
Comprehensive information is needed on the scope of the problem of AMR, particularly outside of hospital settings (e.g., how are antimicrobials being used; how many bacteria are resistant; to which drugs; how are they being spread). This information is necessary to determine the full magnitude of the problem and is essential to monitor the effectiveness of stewardship interventions-this information can only be gathered from effective surveillance.
In Canada, there are already robust surveillance systems in place, and we will continue these existing surveillance activities, as well as the supporting laboratory services, in support of efforts to combat AMR. These systems will also be built upon to enhance our surveillance of AMR. Examples of some of the deliverables under this action area include: 
Stewardship
AMR occurs whenever antimicrobials are used and will therefore be a constant factor in both human and veterinary medicine. Strong stewardship practices by everyone are therefore essential to continue to combat AMR. Given the importance of stewardship, a number of activities are outlined under the two actions in this area.
Action 2: Strengthen the promotion of the appropriate use of antimicrobials in human and veterinary medicine.
An important consideration in preserving the effectiveness of existing antimicrobial drugs is promoting disease prevention efforts with the aim of minimizing or eliminating the need for antimicrobials. In addition to infection prevention and control, the Government of Canada will continue efforts to facilitate and enhance education and awareness on when and how to use antimicrobials, as well as the choice of the correct antimicrobials to use for treatment of certain conditions. In addition, significant progress in the agri-food sector has been made to promote the prudent use of antimicrobials in food animal production. Key activities moving forward involving both sectors include:
 The Public Health Agency of Canada will build on lessons learned from the November 2014 AMR awareness campaign to inform future public awareness and education activities for the general public, and for health professionals working in community, hospital and long-term care settings. In addition to efforts to improve infection prevention and control measures, as well as promote education and awareness, the Government of Canada has an important role in the regulation of animal health products in Canada, including the importation, licensing, and sale of veterinary drugs, medicated feeds, and vaccines. In support of this role, the following activities will be undertaken:  Agriculture and Agri-food Canada will continue to support and/or undertake research and innovation on improvements in animal production practices, disease prevention and treatment, and development of vaccines, which will contribute to reducing the requirements for antimicrobials in the animal production industry. (Ongoing)  The Canadian Institutes of Health Research will continue to build knowledge to create innovative tools and alternative therapies to prevent and limit the spread of AMR through research and development via both open competition and strategic funding through partnerships, and in particular collaboration with international groups to promote and leverage Canadian contributions within international research teams. (Ongoing)
Moving forward
The Government of Canada remains committed to taking action on AMR and AMU. As such, we will continue to work with federal, provincial, territorial, and international health and agriculture partners, as well as other stakeholders, to identify how we can strengthen existing and planned activities. We will also continue to work to identify new activities to help combat the spread of AMR. The Federal Action Plan is the first in a series to keep Canadians informed of our activities and our ongoing progress in implementing the Federal Framework.
